首页> 外文期刊>Nature >A critical role for IGF-II in memory consolidation and enhancement
【24h】

A critical role for IGF-II in memory consolidation and enhancement

机译:IGF-II在内存整合和增强中的关键作用

获取原文
获取原文并翻译 | 示例
           

摘要

We report that, in the rat, administering insulin-like growth factor II (IGF-II, also known as IGF2) significantly enhances memory retention and prevents forgetting. Inhibitory avoidance learning leads to an increase in hippocampal expression of IGF-II, which requires the transcription factor CCAAT enhancer binding protein β and is essential for memory consolidation. Furthermore, injections of recombinant IGF-II into the hippocampus after either training or memory retrieval significantly enhance memory retention and prevent forgetting. To be effective, IGF-H needs to be administered within a sensitive period of memory consolidation. IGF-II-dependent memory enhancement requires IGF-II receptors, new protein synthesis, the function of activity-regulated cytoskelet al-associated protein and glycogen-synthase kinase 3 (GSK3). Moreover, it correlates with a significant activation of synaptic GSK3β and increased expression of GluR1 (also known as GRIA1) α-amino-3-hydroxy-5-methyl-4-isoxasolepropionic acid receptor subunits. In hippocampal slices, IGF-II promotes IGF-II receptor-dependent, persistent long-term potentiation after weak synaptic stimulation. Thus, IGF-II may represent a novel target for cognitive enhancement therapies.
机译:我们报道,在大鼠中,施用胰岛素样生长因子II(IGF-II,也称为IGF2)可以显着增强记忆力并防止遗忘。抑制性避免学习导致IGF-II在海马中的表达增加,这需要转录因子CCAAT增强子结合蛋白β,对于记忆巩固至关重要。此外,在训练或记忆恢复后向海马注射重组IGF-II可显着增强记忆保持并防止遗忘。为有效起见,IGF-H需要在记忆巩固的敏感期内使用。 IGF-II依赖的记忆增强需要IGF-II受体,新的蛋白质合成,活性调节的细胞骨架Al相关蛋白和糖原合酶激酶3(GSK3)的功能。此外,它与突触GSK3β的显着活化和GluR1(也称为GRIA1)α-氨基-3-羟基-5-甲基-4-异xasole丙酸受体亚基的表达增加有关。在海马切片中,IGF-II会在弱突触刺激后促进IGF-II受体依赖性的持续长期增强作用。因此,IGF-II可能代表认知增强疗法的新目标。

著录项

  • 来源
    《Nature》 |2011年第7331期|p.491-497|共7页
  • 作者单位

    Department of Neuroscience, Mount Sina School of Medicine, New York, New York 10029, USA;

    Department of Neuroscience, Mount Sina School of Medicine, New York, New York 10029, USA;

    Department of Neuroscience, Mount Sina School of Medicine, New York, New York 10029, USA ,CIMA, University of Navarra, CIBERNED, Pamplona 31008, Spain;

    Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, New York 10029, USA;

    Department of Neuroscience, Mount Sina School of Medicine, New York, New York 10029, USA;

    Department of Neuroscience, Mount Sina School of Medicine, New York, New York 10029, USA;

    Department of Pharmacology and Systems Therapeutics, Mount Sinai School of Medicine, New York, New York 10029, USA,Department of Psychiatry, Mount Sinai School of Medicine, New York, New York 10029, USA;

    Department of Neuroscience, Mount Sina School of Medicine, New York, New York 10029, USA ,Department of Psychiatry, Mount Sinai School of Medicine, New York, New York 10029, USA;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号